MORGAN STANLEY - CELLECT BIOTECHNOLOGY LTD ownership

CELLECT BIOTECHNOLOGY LTD's ticker is APOP and the CUSIP is 15116C102. A total of 12 filers reported holding CELLECT BIOTECHNOLOGY LTD in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of CELLECT BIOTECHNOLOGY LTD
ValueSharesWeighting
Q3 2019$01
-50.0%
0.00%
Q2 2019$0
-100.0%
2
-100.0%
0.00%
Q1 2019$18,000
-43.8%
18,005
+20.0%
0.00%
Q4 2018$32,000
-54.9%
15,0050.0%0.00%
Q3 2018$71,000
-41.3%
15,005
-11.0%
0.00%
Q2 2018$121,000
+27.4%
16,869
+13.5%
0.00%
Q1 2018$95,000
+37.7%
14,869
+50.7%
0.00%
Q4 2017$69,000
-11.5%
9,8640.0%0.00%
Q3 2017$78,000
-2.5%
9,8640.0%0.00%
Q2 2017$80,000
-52.9%
9,864
-50.0%
0.00%
Q1 2017$170,00019,7280.00%
Other shareholders
CELLECT BIOTECHNOLOGY LTD shareholders Q1 2019
NameSharesValueWeighting ↓
DEUTSCHE BANK AG\ 500$4,0000.00%
CITIGROUP INC 2,800$23,0000.00%
MORGAN STANLEY 9,864$80,0000.00%
Psagot Value Holdings Ltd. 186$1,0000.00%
Tower Research Capital LLC (TRC) 300$2,0000.00%
UBS Group AG 1,786$14,0000.00%
View complete list of CELLECT BIOTECHNOLOGY LTD shareholders